<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05021042</url>
  </required_header>
  <id_info>
    <org_study_id>LactApp001</org_study_id>
    <nct_id>NCT05021042</nct_id>
  </id_info>
  <brief_title>Identification of Biomarkers of Mastitis</brief_title>
  <official_title>Identification of Predictive Biomarkers of Mastitis in Lactating Mothers Using a Metabolomic Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LactApp Women's Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LactApp Women's Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breastfeeding is the optimal feeding for infants. WHO currently promotes breastfeeding and&#xD;
      recommends it to be exclusive until the baby is 6 months old. Breastfeeding has a positive&#xD;
      impact on both the mother's and the infant's health and is directly associated with the&#xD;
      decrease in diseases such as cancer, diabetes, cardiovascular disease, and inflammatory and&#xD;
      infectious diseases. Currently, in Spain, only 39% of infants at 6 months are breastfed. The&#xD;
      factors that influence the abandonment of breastfeeding are returning to work, the sensation&#xD;
      of hypogalactia, problems to breastfeed, and breast complications, like mastitis, being the&#xD;
      pain its main cause. Recent studies have associated pain while breastfeeding with mammary&#xD;
      gland inflammation (mastitis) caused by dysbiosis.&#xD;
&#xD;
      In order to increase breastfeeding rates, it is necessary to find factors related to the&#xD;
      progression of mastitis in breastfeeding women. In this context, the discovery of predictive&#xD;
      biomarkers based on metabolic markers is key to act before or at the beginning of the&#xD;
      progression of mastitis and thus reduce the rates of abandonment of breastfeeding due to&#xD;
      pain.&#xD;
&#xD;
      The present project aims to identify and validate metabolic biomarkers capable of predicting&#xD;
      mastitis. For this purpose, a prospective observational case-control hypothesis-free study&#xD;
      will be carried out in order to identify and validate biomarkers of mastitis in breastfeeding&#xD;
      women. The study will be performed in two phases: the discovery of the possible biomarkers&#xD;
      and the validation of the biomarkers.&#xD;
&#xD;
      Breast milk will be collected at the beginning of the study and when women present symptoms&#xD;
      compatible with mastitis. The presence or not of mastitis will be confirmed with a milk&#xD;
      culture. Milk samples will be analyzed using non-targeted metabolomics approach. Using&#xD;
      multivariate statistical models, the potential metabolites capable of discriminating the&#xD;
      presence of mastitis in maternal milk will be identified. Later, these potential markers will&#xD;
      be validated in independent samples.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Breast milk metabolites</measure>
    <time_frame>6 months</time_frame>
    <description>Breast milk Metabolite will be identified by NMR metabolomic analysis. Analytes will be quantified in mg/mL</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Breast Feeding</condition>
  <condition>Mastitis</condition>
  <condition>Mastitis Acute Female</condition>
  <arm_group>
    <arm_group_label>Acute mastitis (MA)</arm_group_label>
    <description>Lactating women with confirmed acute mastitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subacute mastitis (SAM)</arm_group_label>
    <description>Lactating women with confirmed subacute mastitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (CT)</arm_group_label>
    <description>Lactating women with the absence of acute or subacute mastitis symptomatology.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Breast milk&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Lactating women will be included in the study. Women with the presence of acute mastitis,&#xD;
        subacute mastitis, and with absence of symptomatology compatible with mastitis will be&#xD;
        recruited as control samples.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Breastfeeding women with healthy full-term, singleton infants older than 1 months&#xD;
             weeks and younger than 6 months.&#xD;
&#xD;
          -  Provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Immunocompromised suppressed women (i.e. HIV, following treatment with&#xD;
             immunosuppressants or chemotherapy).&#xD;
&#xD;
          -  Currently being treated for cancer&#xD;
&#xD;
          -  Current infection being treated with antibiotics.&#xD;
&#xD;
          -  Women who carry out a complete deferred breastfeeding.&#xD;
&#xD;
          -  Women with babies presenting any syndrome, cleft lip or facial malformations.&#xD;
&#xD;
          -  Currently tandem breastfeeding.&#xD;
&#xD;
          -  Women who have had a premature delivery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>LactApp Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paola Quifer-Rada, PhD</last_name>
      <email>paola@lactapp.es</email>
    </contact>
    <contact_backup>
      <last_name>Laia Aguilar-Camprubí</last_name>
      <email>laia@lactapp.es</email>
    </contact_backup>
    <investigator>
      <last_name>Alba Padró-Arocas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paola Quifer-Rada, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laia Aguilar-Camprubí</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Desirée Mena-Tudela, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>https://lactapp.com/</url>
    <description>Related Info</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 11, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>LactApp Women's Health</investigator_affiliation>
    <investigator_full_name>Paola Quifer Rada</investigator_full_name>
    <investigator_title>Clinical Data Researcher</investigator_title>
  </responsible_party>
  <keyword>breastfeeding</keyword>
  <keyword>breast milk</keyword>
  <keyword>mastitis</keyword>
  <keyword>acute mastitis</keyword>
  <keyword>subacute mastitis</keyword>
  <keyword>biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mastitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

